COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,537 Articles (22,881 medRxiv, 8,656 bioRxiv)

Most recent first Previous |  Page 792: Articles 7911-7920  | Next

Comparison of the burnout among medical residents before and during the pandemic: not more exhausted but less accomplished
Kücükali, H., Türkoglu, S. N., Hasanli, S., Dayanır Cok, F. N., Culpan, H. C., Hayran, O.
10.1101/2022.05.28.22275707 — Posted: 2022-05-29
Identifying COVID-19 phenotypes using cluster analysis and assessing their clinical outcomes
Yamga, E., Mullie, L., Durand, M., Cadrin-Chenevert, A., Tang, A., Montagnon, E., Chartrand-Lefebvre, C., Chasse, M.
10.1101/2022.05.27.22275708 — Posted: 2022-05-29
The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe
G. Monfared, I.
10.1101/2022.05.24.22275504 — Posted: 2022-05-29
Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations
Hoffman, K. L., Schenck, E. J., Satlin, M. J., Whalen, W., Pan, D., Williams, N., Diaz, I.
10.1101/2022.05.27.22275037 — Posted: 2022-05-29
The effect of vasopressors on mortality in critically ill patients with COVID-19: A systematic review and meta-analysis
Mermiri, M., Mavrovounis, G., Laou, E., Papagiannakis, N., Pantazopoulos, I., Chalkias, A.
10.1101/2022.05.27.22275715 — Posted: 2022-05-28
Association between Self-reported Masking Behavior and SARS-CoV-2 Infection Wanes from Pre-Delta to Omicron-Predominant Periods - North Carolina COVID-19 Community Research Partnership
Tjaden, A. H., Gibbs, M. A., Runyon, M., Weintraub, W. S., Taylor, Y. J., Edelstein, S. L., COVID-19 Community Research Partnership Study Group
10.1101/2022.05.27.22275689 — Posted: 2022-05-28
A pharmacoepidemiological study of myocarditis and pericarditis following mRNA COVID-19 vaccination in Europe
Tome, J., Cowan, L. T., Fung, I. C.-H.
10.1101/2022.05.27.22275706 — Posted: 2022-05-28
CMV seropositivity in older adults changes T cell functionality, but does not prevent antibody or cellular SARS-CoV-2 vaccine responses
Breznik, J. A., Huynh, A., Zhang, A., Bilaver, L., Bhakta, H., Stacey, H. D., Ang, J. C., Bramson, J. L., Nazy, I., Miller, M. S., Denburg, J., Costa, A. P., Bowdish, D. M. E., COVID-in-LTC Study Group
10.1101/2022.05.27.22275673 — Posted: 2022-05-28
A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021
Wulf Hanson, S., Abbafati, C., Aerts, J. G., Al-Aly, Z., Ashbaugh, C., Ballouz, T., Blyuss, O., Bobkova, P., Bonsel, G., Borzakova, S., Buonsenso, D., Butnaru, D., Carter, A., Chu, H., De Rose, C., Diab, M. M., Ekbom, E., El Tantawi, M., Fomin, V., Frithiof, R., Gamirova, A., Glybochko, P. V., Haagsma, J. A., Haghjooy Javanmard, S., Hamilton, E. B., Harris, G., Heijenbrok-Kal, M. H., Helbok, R., Hellemons, M. E., Hillus, D., Huijts, S. M., Hultstrom, M., Jassat, W., Kurth, F., Larsson, I.-M., Lipcsey, M., Liu, C., Loflin, C. D., Malinovschi, A., Mao, W., Mazankova, L., McCulloch, D., Menges, D
10.1101/2022.05.26.22275532 — Posted: 2022-05-27
Intrahost evolution and forward transmission of a novel SARS-CoV-2 Omicron BA.1 subvariant
Gonzalez-Reiche, A. S., Alshammary, H., Schaefer, S., Patel, G., Polanco, J., Amoako, A., Rooker, A., Cognigni, C., Floda, D., van de Guchte, A., Khalil, Z., Farrugia, K., Assad, N., Zhang, J., Alburquerque, B., Sominsky, L., Srivastava, K., Sebra, R., Ramirez, J. D., Banu, R., Shrestha, P., Paniz-Mondolfi, A., Sordillo, E. M., Simon, V., van Bakel, H.
10.1101/2022.05.25.22275533 — Posted: 2022-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).